Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 138 of the 138 references it cites were found in a registry or an index.

Organoids-on-a-chip: microfluidic technology enables culture of organoids with enhanced tissue function and potential for disease modeling

Open access
Papamichail, Lito, Koch, Lena S., Veerman, Devin, Broersen, Kerensa, van der Meer, Andries D. · 2025 · Frontiers in Bioengineering and Biotechnology

Abstract

Organoids are stem-cell derived tissue structures mimicking specific structural and functional characteristics of human organs. Despite significant advancements in the field over the last decade, challenges like limited long-term functional culture and lack of maturation are hampering the implementation of organoids in biomedical research. Culture of organoids in microfluidic chips is being used to tackle these challenges through dynamic and precise control over the organoid microenvironment. This review highlights the significant breakthroughs that have been made in the innovative field of “organoids-on-chip,” demonstrating how these have contributed to advancing organoid models. We focus on the incorporation of organoids representative for various tissues into chips and discuss the latest findings in multi-organoids-on-chip approaches. Additionally, we examine current limitations and challenges of the field towards the development of reproducible organoids-on-chip systems. Finally, we discuss the potential of organoids-on-chip technology for both in vitro and in vivo applications.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fbioe.2025.1515340

Cites

138 of 138 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIGURE 1 Schematic representation of methods used to integrate, culture, and analyze organoids in chip devices. (A) Human pluripotent stem cells (hPSCs), adult stem cells (ASCs), or primary cells are used to form spheroids or organoids according to standard culture protocols. Subsequently, the spheroids/organoids are either mixed with a gel-like matrix and then transferred into the culture chambers of the chip or transferred into a chip pre-coated with a gel-like matrix. Alternatively, the spheroids/organoids are dissociated into single cells which are then mixed with a gel-like matrix and transferred into the culture chambers of the chip. The spheroid/organoid-derived single cells are then organized again into spheroid/organoid structures during the on-chip culture. In all three cases the on-chip spheroid/organoid culture is performed under flow which ensures sufficient medium perfusion. (B) The downstream analysis of the organoids cultured into microfluidic chips can be conducted either directly on chip or after the retrieval of organoids from the chip depending on the design of the system used and the nature of the subsequent analysis. Created in BioRender. Papamichail, L. (2025) https://BioRender.com/a07j366.
FIGURE 1 Schematic representation of methods used to integrate, culture, and analyze organoids in chip devices. (A) Human pluripotent stem cells (hPSCs), adult stem cells (ASCs), or primary cells are used to form spheroids or organoids according to standard culture protocols. Subsequently, the spheroids/organoids are either mixed with a gel-like matrix and then transferred into the culture chambers of the chip or transferred into a chip pre-coated with a gel-like matrix. Alternatively, the spheroids/organoids are dissociated into single cells which are then mixed with a gel-like matrix and transferred into the culture chambers of the chip. The spheroid/organoid-derived single cells are then organized again into spheroid/organoid structures during the on-chip culture. In all three cases the on-chip spheroid/organoid culture is performed under flow which ensures sufficient medium perfusion. (B) The downstream analysis of the organoids cultured into microfluidic chips can be conducted either directly on chip or after the retrieval of organoids from the chip depending on the design of the system used and the nature of the subsequent analysis. Created in BioRender. Papamichail, L. (2025) https://BioRender.com/a07j366.CC BY · PubMed Central
FIGURE 2 Schematic representation depicting how organoid-on-chip technology can contribute to addressing the major limitations of typical organoid culture. The flow of culture medium through the microfluidic perfusable network in the chip mimics in vivo vasculature-based nutrient transfer; addresses the limitation of passive nutrient diffusion on the extended culture and growth of organoids (top left). The application of flow and pressure through the chip device recapitulates in vivo biomechanical factors; addresses the lack of biomechanical stimulation important for the further organoid maturation (top right). The possibility of co-culturing different types of organoids provides the opportunity to capture in vivo organ-organ interactions; it overcomes the lack of organ-level communication during the standard single-type organoid culture (bottom left). Platforms that permit automated, high-throughput on-chip culture can be used to reduce organoid variability observed for standard organoid culture methods (adapted from Schuster et al., Nat Commun, 2020, CC BY 4.0 (Schuster et al., 2020)) (bottom right). Created in BioRender. Papamichail, L. (2025) https://BioRender.com/o40q718.
FIGURE 2 Schematic representation depicting how organoid-on-chip technology can contribute to addressing the major limitations of typical organoid culture. The flow of culture medium through the microfluidic perfusable network in the chip mimics in vivo vasculature-based nutrient transfer; addresses the limitation of passive nutrient diffusion on the extended culture and growth of organoids (top left). The application of flow and pressure through the chip device recapitulates in vivo biomechanical factors; addresses the lack of biomechanical stimulation important for the further organoid maturation (top right). The possibility of co-culturing different types of organoids provides the opportunity to capture in vivo organ-organ interactions; it overcomes the lack of organ-level communication during the standard single-type organoid culture (bottom left). Platforms that permit automated, high-throughput on-chip culture can be used to reduce organoid variability observed for standard organoid culture methods (adapted from Schuster et al., Nat Commun, 2020, CC BY 4.0 (Schuster et al., 2020)) (bottom right). Created in BioRender. Papamichail, L. (2025) https://BioRender.com/o40q718.CC BY · PubMed Central
FIGURE 3 Major advances in organoids-on-chip technology, focusing on the incorporation of brain (A), retinal (B), kidney (C), liver (D), gastrointestinal tract (E), and multi-organoids (F) into chips. Brain organoids cultured into chips overall present increased diameter size and higher structural complexity and functionality. Applications of brain organoids-on-chip systems led to insights into mechanisms underlying brain development and enabled modelling of brain developmental disorders and toxicity screening studies (A). Nuclei staining of hMOs derived from two different neuroepithelial stem cell lines (NESC) showing reduced necrotic core formation under controlled fluidic conditions compared to common shaking culture (scale bars = 200 μm, adapted from Berger et al., Lab on a Chip, 2018, CC BY 3.0 (Berger et al., 2018)) (A1). Immunostaining of neural progenitor marker SOX2 and radial glia marker phosphorylated vimentin (p-Vim) show increased glia generation in chip-culture of brain organoids compared to plate-culture, indicating increased organoid maturation (scale bar = 50 μm, adapted from Cho et al., Nat Commun, 2021, CC BY 4.0 (Cho et al., 2021)) (A2). Immunostaining of basal layer marker SOX2 showing increased cortical organization and higher structural complexity of brain organoids cultured into chip versus on well-plate (scale bars = 50 μm, adapted from Cho et al., Nat Commun, 2021, CC BY 4.0 (Cho et al., 2021)) (A3). Immunostaining for early-born neuron marker CTIP2 and preplate marker TBR1 show enhanced spatial cortical neuronal organization of organoids cultured in chips versus Petri dishes (scale bars = 50 μm, adapted from Wang et al., RSC Advances, 2018, CC BY NC 3.0 DEED (Wang et al., 2018a)) (A4). Retinal organoids cultured into chips demonstrate higher structural complexity and enhanced maturation. Applications of retinal organoids-on-chip systems led to insights into mechanisms underlying retinal ganglion cell (RGC) development and enabled disease modelling of retinal diseases and drug screening studies (B). Schematic representation of organ-on-chip system used for the co-culture of retinal organoids (ROs) with RPE cells (B1a). Live-cell imaging shows the interaction between pJG-IRBP-GFP viral vector-labelled RPE cells and PNA lectin-Alexa Fluor 568-labelled ROs (scale bar = 40 μm) (B1b, top). Immunostaining of rhodopsin (green) and phalloidin (red) reveals a defined interaction of ROs and RPE cells (scale bar = 40 μm) (B1b, bottom). Graph depicting distance between GFP-labelled RPE cells and lectin-labelled segment tips (figures B1a–c adapted from Achberger et al., eLife, 2019, CC BY 4.0 (Achberger et al., 2019)) (B1c). Immunostaining of laminin (red) showing increased expression in ROs cultured under perfusion compared to static conditions (scale bars = 100 μm, adapted from Su et al., Front. Bioeng. Biotechnol., 2022, CC BY 4.0 (Su et al., 2022)) (B2). Immunostaining of collagen IV (red) showing increased expression in ROs cultured under perfusion compared to static conditions (scale bars = 100 μm, adapted from Su et al., Front. Bioeng. Biotechnol., 2022, CC BY 4.0 (Su et al., 2022)) (B3). Kidney organoids cultured into chips demonstrate increased structural and functional maturation and higher degree of vascularization. Applications of kidney organoids-on-chips resulted in insights into glomerular vascularization and facilitated drug nephrotoxicity evaluation studies (C). Immunostaining for nuclei (DAPI/blue), HUVECs (PECAM/red+, GFP+), and native ECs (PECAM/red+, GFP−) showing vascular structures combinatorically formed by both HUVECs and native ECs (scale bars = 200 μm, adapted from Bas-Cristóbal Menéndez, A., Du, Z., van den Bosch, T.P.P. et al., Sci Rep, 2022, CC BY 4.0 (Bas-Cristóbal Menéndez et al., 2022)) (C1). Immunostaining of nuclei (DAPI/blue), MCAM (green), and PECAM (red) revealing increased MCAM+ and PECAM + areas during on-chip conditions compared to static (scale bars = 200 μm, adapted from Bas-Cristóbal Menéndez, A., Du, Z., van den Bosch, T.P.P. et al., Sci Rep, 2022, CC BY 4.0 (Bas-Cristóbal Menéndez et al., 2022)) (C2). Live (green)/dead (red) staining of untreated (control) kidney organoids and kidney organoids treated with tacrolimus shows increased tacrolimus-mediated cell death of kidney organoids cultured under flow versus static conditions (scale bars = 100 μm, adapted from Lee. H. N. et al., Nano Convergence, 2021, CC BY 4.0 (Lee et al., 2021)) (C3). Liver organoids cultured into chips demonstrate higher structural complexity and enhanced maturation and functionality. Applications of liver organoids-on-chip systems include disease modelling and drug screening studies (D). Immunofluorescent staining for MRP2 (red) and ZO-1 (green) showing more prominent and structured expression in culture under flow compared to static (scale bars = 100 μm, adapted from Byeon et al., Front. Cell Dev. Biol., 2024, CC BY 4.0 (Byeon et al., 2024)) (D1). Immunofluorescent staining for albumin (green) revealing higher expression in culture under flow compared to static (scale bars = 100 μm, adapted from Byeon et al., Front. Cell Dev. Biol., 2024, CC BY 4.0 (Byeon et al., 2024)) (D2). Gastrointestinal organoids cultured into chips show better recapitulation of the in vivo structural architecture, prolonged culture possibilities, enhanced organoid maturation and permit introduction of laminar flow. Applications of gastrointestinal organoids-on-chip systems include modelling of biology and disease with a focus on host-microorganism interactions and regeneration processes (E). Demonstration of laminar flow introduction in intestinal organoids showing expansion and contraction of the organoids in accordance with flow application and/or direction conditions (adapted from Sidar et al., Lab-on-a-Chip, 2019, CC BY-NC 3.0 (Sidar et al., 2019) (E1). Time-course images of DSS-injured epithelium showing epithelial regeneration 10 days post-injury (Reprinted by permission from Nikolaev, M., Mitrofanova, O., Broguiere, N. et al., Copyright 2020, Springer Nature (Nikolaev et al., 2020)) (E2a). Immunostaining of epithelial intestinal cells (nuclei/DAPI-blue, actin filaments/E-cadherin-green) and parasite C. parvum (oocyst outer walls/Crypt-a-Glo-red) demonstrating the infection progression of the intestinal epithelium (Reprinted by permission from Nikolaev, M., Mitrofanova, O., Broguiere, N. et al., Copyright 2020, Springer Nature (Nikolaev et al., 2020)) (E2b). Key findings in multi-organoids-on-chip systems enabled the assessment of drug response at a multi-organ level, the development of a single chip system combining features of six different organs and the design of platforms with higher prediction accuracy of drug toxicity (F). Live/dead (green/red) staining of co-cultured lung, liver, and cardiac constructs with and without bleomycin treatment demonstrating the application of multi-organoid-on-chip platforms on drug response assessment at a multi-organ level (adapted from Skardal et al., Scientific Reports, 2017, CC BY 4.0 (Skardal et al., 2017)) (F1). Plots depicting beating of cardiac organoids in different experimental conditions revealing a substantially more prominent effect of bleomycin in on-chip co-culture conditions (three-organoids) compared to mono-culture ones (heart only) (adapted from Skardal et al., Scientific Reports, 2017, CC BY 4.0 (Skardal et al., 2017)) (F2). Created in BioRender. Papamichail, L. (2025) https://BioRender.com/d31m438 (A), https://BioRender.com/d31m438 (B), https://BioRender.com/d31m438 (C).
FIGURE 3 Major advances in organoids-on-chip technology, focusing on the incorporation of brain (A), retinal (B), kidney (C), liver (D), gastrointestinal tract (E), and multi-organoids (F) into chips. Brain organoids cultured into chips overall present increased diameter size and higher structural complexity and functionality. Applications of brain organoids-on-chip systems led to insights into mechanisms underlying brain development and enabled modelling of brain developmental disorders and toxicity screening studies (A). Nuclei staining of hMOs derived from two different neuroepithelial stem cell lines (NESC) showing reduced necrotic core formation under controlled fluidic conditions compared to common shaking culture (scale bars = 200 μm, adapted from Berger et al., Lab on a Chip, 2018, CC BY 3.0 (Berger et al., 2018)) (A1). Immunostaining of neural progenitor marker SOX2 and radial glia marker phosphorylated vimentin (p-Vim) show increased glia generation in chip-culture of brain organoids compared to plate-culture, indicating increased organoid maturation (scale bar = 50 μm, adapted from Cho et al., Nat Commun, 2021, CC BY 4.0 (Cho et al., 2021)) (A2). Immunostaining of basal layer marker SOX2 showing increased cortical organization and higher structural complexity of brain organoids cultured into chip versus on well-plate (scale bars = 50 μm, adapted from Cho et al., Nat Commun, 2021, CC BY 4.0 (Cho et al., 2021)) (A3). Immunostaining for early-born neuron marker CTIP2 and preplate marker TBR1 show enhanced spatial cortical neuronal organization of organoids cultured in chips versus Petri dishes (scale bars = 50 μm, adapted from Wang et al., RSC Advances, 2018, CC BY NC 3.0 DEED (Wang et al., 2018a)) (A4). Retinal organoids cultured into chips demonstrate higher structural complexity and enhanced maturation. Applications of retinal organoids-on-chip systems led to insights into mechanisms underlying retinal ganglion cell (RGC) development and enabled disease modelling of retinal diseases and drug screening studies (B). Schematic representation of organ-on-chip system used for the co-culture of retinal organoids (ROs) with RPE cells (B1a). Live-cell imaging shows the interaction between pJG-IRBP-GFP viral vector-labelled RPE cells and PNA lectin-Alexa Fluor 568-labelled ROs (scale bar = 40 μm) (B1b, top). Immunostaining of rhodopsin (green) and phalloidin (red) reveals a defined interaction of ROs and RPE cells (scale bar = 40 μm) (B1b, bottom). Graph depicting distance between GFP-labelled RPE cells and lectin-labelled segment tips (figures B1a–c adapted from Achberger et al., eLife, 2019, CC BY 4.0 (Achberger et al., 2019)) (B1c). Immunostaining of laminin (red) showing increased expression in ROs cultured under perfusion compared to static conditions (scale bars = 100 μm, adapted from Su et al., Front. Bioeng. Biotechnol., 2022, CC BY 4.0 (Su et al., 2022)) (B2). Immunostaining of collagen IV (red) showing increased expression in ROs cultured under perfusion compared to static conditions (scale bars = 100 μm, adapted from Su et al., Front. Bioeng. Biotechnol., 2022, CC BY 4.0 (Su et al., 2022)) (B3). Kidney organoids cultured into chips demonstrate increased structural and functional maturation and higher degree of vascularization. Applications of kidney organoids-on-chips resulted in insights into glomerular vascularization and facilitated drug nephrotoxicity evaluation studies (C). Immunostaining for nuclei (DAPI/blue), HUVECs (PECAM/red+, GFP+), and native ECs (PECAM/red+, GFP−) showing vascular structures combinatorically formed by both HUVECs and native ECs (scale bars = 200 μm, adapted from Bas-Cristóbal Menéndez, A., Du, Z., van den Bosch, T.P.P. et al., Sci Rep, 2022, CC BY 4.0 (Bas-Cristóbal Menéndez et al., 2022)) (C1). Immunostaining of nuclei (DAPI/blue), MCAM (green), and PECAM (red) revealing increased MCAM+ and PECAM + areas during on-chip conditions compared to static (scale bars = 200 μm, adapted from Bas-Cristóbal Menéndez, A., Du, Z., van den Bosch, T.P.P. et al., Sci Rep, 2022, CC BY 4.0 (Bas-Cristóbal Menéndez et al., 2022)) (C2). Live (green)/dead (red) staining of untreated (control) kidney organoids and kidney organoids treated with tacrolimus shows increased tacrolimus-mediated cell death of kidney organoids cultured under flow versus static conditions (scale bars = 100 μm, adapted from Lee. H. N. et al., Nano Convergence, 2021, CC BY 4.0 (Lee et al., 2021)) (C3). Liver organoids cultured into chips demonstrate higher structural complexity and enhanced maturation and functionality. Applications of liver organoids-on-chip systems include disease modelling and drug screening studies (D). Immunofluorescent staining for MRP2 (red) and ZO-1 (green) showing more prominent and structured expression in culture under flow compared to static (scale bars = 100 μm, adapted from Byeon et al., Front. Cell Dev. Biol., 2024, CC BY 4.0 (Byeon et al., 2024)) (D1). Immunofluorescent staining for albumin (green) revealing higher expression in culture under flow compared to static (scale bars = 100 μm, adapted from Byeon et al., Front. Cell Dev. Biol., 2024, CC BY 4.0 (Byeon et al., 2024)) (D2). Gastrointestinal organoids cultured into chips show better recapitulation of the in vivo structural architecture, prolonged culture possibilities, enhanced organoid maturation and permit introduction of laminar flow. Applications of gastrointestinal organoids-on-chip systems include modelling of biology and disease with a focus on host-microorganism interactions and regeneration processes (E). Demonstration of laminar flow introduction in intestinal organoids showing expansion and contraction of the organoids in accordance with flow application and/or direction conditions (adapted from Sidar et al., Lab-on-a-Chip, 2019, CC BY-NC 3.0 (Sidar et al., 2019) (E1). Time-course images of DSS-injured epithelium showing epithelial regeneration 10 days post-injury (Reprinted by permission from Nikolaev, M., Mitrofanova, O., Broguiere, N. et al., Copyright 2020, Springer Nature (Nikolaev et al., 2020)) (E2a). Immunostaining of epithelial intestinal cells (nuclei/DAPI-blue, actin filaments/E-cadherin-green) and parasite C. parvum (oocyst outer walls/Crypt-a-Glo-red) demonstrating the infection progression of the intestinal epithelium (Reprinted by permission from Nikolaev, M., Mitrofanova, O., Broguiere, N. et al., Copyright 2020, Springer Nature (Nikolaev et al., 2020)) (E2b). Key findings in multi-organoids-on-chip systems enabled the assessment of drug response at a multi-organ level, the development of a single chip system combining features of six different organs and the design of platforms with higher prediction accuracy of drug toxicity (F). Live/dead (green/red) staining of co-cultured lung, liver, and cardiac constructs with and without bleomycin treatment demonstrating the application of multi-organoid-on-chip platforms on drug response assessment at a multi-organ level (adapted from Skardal et al., Scientific Reports, 2017, CC BY 4.0 (Skardal et al., 2017)) (F1). Plots depicting beating of cardiac organoids in different experimental conditions revealing a substantially more prominent effect of bleomycin in on-chip co-culture conditions (three-organoids) compared to mono-culture ones (heart only) (adapted from Skardal et al., Scientific Reports, 2017, CC BY 4.0 (Skardal et al., 2017)) (F2). Created in BioRender. Papamichail, L. (2025) https://BioRender.com/d31m438 (A), https://BioRender.com/d31m438 (B), https://BioRender.com/d31m438 (C).CC BY · PubMed Central
FIGURE 4 Schematic representations of different chip system designs. (A) Pump-free, gravity-driven fluidic system used to culture brain organoids and mimic bi-directional cerebrospinal flow in vitro (adapted from Cho et al., Nat Commun, 2021, CC BY 4.0 (Cho et al., 2021). (B) Peristaltic pump-based system used to culture human midbrain-specific organoids (hMOs), featuring four interconnected six-chamber circuits (adapted from Berger et al., Lab on a Chip, 2018, CC BY 3.0 (Berger et al., 2018)). (C) Syringe pump-based system used to culture kidney organoids and promote vascularization (adapted from Lee. H. N. et al., Nano Convergence, 2021, CC BY 4.0 (Lee et al., 2021)). (D) Peristaltic pump-based, multi-organoid system featuring three interconnected individual fluidic units each one used for the integration of a different organoid type (adapted from Skardal et al., Scientific Reports, 2017, CC BY 4.0 (Skardal et al., 2017)). (E) System featuring three interconnected microfluidic large-scale integration (mLSI) chips, each one consisting of 64 cell culture microchambers. The design enables automatic operation of the microfluidic building blocks (MFBBs) through a single fluidic circuit board (FCB) (adapted from Vollertsen et al., Microsystems and Nanoengineering, 2020 CC BY 4.0 (Vollertsen et al., 2020)). Created in BioRender. Papamichail, L. (2025) https://BioRender.com/l34j257.
FIGURE 4 Schematic representations of different chip system designs. (A) Pump-free, gravity-driven fluidic system used to culture brain organoids and mimic bi-directional cerebrospinal flow in vitro (adapted from Cho et al., Nat Commun, 2021, CC BY 4.0 (Cho et al., 2021). (B) Peristaltic pump-based system used to culture human midbrain-specific organoids (hMOs), featuring four interconnected six-chamber circuits (adapted from Berger et al., Lab on a Chip, 2018, CC BY 3.0 (Berger et al., 2018)). (C) Syringe pump-based system used to culture kidney organoids and promote vascularization (adapted from Lee. H. N. et al., Nano Convergence, 2021, CC BY 4.0 (Lee et al., 2021)). (D) Peristaltic pump-based, multi-organoid system featuring three interconnected individual fluidic units each one used for the integration of a different organoid type (adapted from Skardal et al., Scientific Reports, 2017, CC BY 4.0 (Skardal et al., 2017)). (E) System featuring three interconnected microfluidic large-scale integration (mLSI) chips, each one consisting of 64 cell culture microchambers. The design enables automatic operation of the microfluidic building blocks (MFBBs) through a single fluidic circuit board (FCB) (adapted from Vollertsen et al., Microsystems and Nanoengineering, 2020 CC BY 4.0 (Vollertsen et al., 2020)). Created in BioRender. Papamichail, L. (2025) https://BioRender.com/l34j257.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 125

Metadata

Authors
Papamichail, L., Koch, L. S., Veerman, D., Broersen, K., & van der Meer, A. D.
Affiliations
  • Erasmus MC (NL)
  • University of Twente (NL)
Corresponding author
  • Koch, Lena S.
  • Broersen, Kerensa
Venue
Frontiers in Bioengineering and Biotechnology
Published
2025-03-11
Volume
13
Pages
1515340-1515340
ISSN
2296-4185 (ISSN-L)
OpenAlex
W4408314573
Cited by
120
References
137
Citations by year
2026: 90 · 2025: 30
FWCI
9.66
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Bioengineering and Biotechnology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • University of Twente Research Information (publishedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek (024.003.001 19424 18958)
  • ZonMw
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
Keywords
microfluidic organoids, organoid culture, organoid maturation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.